Aligos Therapeutics, Inc. (ALGS): Capital Expenditures
$130.0K
Year ended 2024-12-31
-47.4%
3-year compound annual growth
-45.8%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $130.0K | +584.2% | 2025-03-10, From 2024-01-01 |
| 2023-12-31 | $19.0K | -98.0% | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | $943.0K | +5.7% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $892.0K | -56.8% | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $2.06M | -25.9% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $2.79M | n/a | 2021-03-23, From 2019-01-01 |